Arcturus Therapeutics Collaborates With Thermo Fisher Scientific To Help Support Phase 3 Development And Potential Commercialization Of ARCT
Strategic manufacturing agreement includes Phase 3 clinical supply and commercial manufacturing rights Arcturus Therapeutics Holdings Inc. (("Arcturus", NASDAQ: ARCT ), a messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics, today announced a strategic collaborat